These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 166448

  • 1. Predictability of response to endocrine ablation in breast cancer.
    Criss WE, Bland KI, O'Leary JP.
    South Med J; 1975 Jun; 68(6):714-6. PubMed ID: 166448
    [Abstract] [Full Text] [Related]

  • 2. Prolactin and breast carcinoma.
    Smithline F, Sherman L, Kolodny D.
    N Engl J Med; 1975 Apr 10; 292(15):784-92. PubMed ID: 1089886
    [Abstract] [Full Text] [Related]

  • 3. Hormones and neoplasia.
    Forrest AP.
    J Clin Pathol Suppl (R Coll Pathol); 1974 Apr 10; 7():65-71. PubMed ID: 4364584
    [No Abstract] [Full Text] [Related]

  • 4. Endocrine therapy of breast cancer.
    McGuire WL.
    Annu Rev Med; 1975 Apr 10; 26():353-63. PubMed ID: 167649
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Endocrine ablation for metastatic breast cancer: a reappraisal of hormone receptors.
    Moseley HS, Peetz ME, Keenan EJ, Awrich AE, Fletcher WS.
    Am J Surg; 1980 Jul 10; 140(1):164-72. PubMed ID: 7396080
    [Abstract] [Full Text] [Related]

  • 10. [Present status of endocrine therapy of breast cancer: a surgeon's view].
    Nomura Y.
    Gan To Kagaku Ryoho; 1984 May 10; 11(5):981-8. PubMed ID: 6426405
    [Abstract] [Full Text] [Related]

  • 11. Endocrine manipulation in the treatment of breast cancer.
    Segaloff A.
    Clin Obstet Gynecol; 1975 Jun 10; 18(2):227-37. PubMed ID: 166781
    [No Abstract] [Full Text] [Related]

  • 12. Estrogen receptors in hormone-dependent breast cancers.
    Jensen EV.
    Cancer Res; 1975 Nov 10; 35(11 Pt. 2):3362-4. PubMed ID: 172222
    [Abstract] [Full Text] [Related]

  • 13. Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation.
    DeSombre ER, Kledzik G, Marshall S, Meites J.
    Cancer Res; 1976 Feb 10; 36(2 Pt 1):354-8. PubMed ID: 177195
    [Abstract] [Full Text] [Related]

  • 14. Estrophilin assays in breast cancer: quantitative features and application to the mastectomy specimen.
    DeSombre ER, Jensen EV.
    Cancer; 1980 Dec 15; 46(12 Suppl):2783-8. PubMed ID: 7448721
    [Abstract] [Full Text] [Related]

  • 15. Endocrine-induced regression of cancers.
    Huggins C.
    Am J Surg; 1978 Aug 15; 136(2):233-8. PubMed ID: 150802
    [No Abstract] [Full Text] [Related]

  • 16. Clinical significance of estrogen receptors in human breast cancer.
    Olsnes S, Pihl A.
    Biomedicine; 1974 Nov 15; 20(6):377-83. PubMed ID: 4376029
    [No Abstract] [Full Text] [Related]

  • 17. Selecting endocrine therapy for metastatic breast cancer.
    McGuire WL.
    Postgrad Med; 1976 Feb 15; 59(2):77-80. PubMed ID: 175359
    [No Abstract] [Full Text] [Related]

  • 18. Hypophysectomy in the treatment of disseminated carcinoma of the breast and prostate gland.
    Tindall GT, Ambrose SS, Christy JH, Patton JM.
    South Med J; 1976 May 15; 69(5):579-83. PubMed ID: 1273614
    [Abstract] [Full Text] [Related]

  • 19. [Hormone dependence and the basis of hormone therapy in breast cancer].
    Martin PM.
    J Gynecol Obstet Biol Reprod (Paris); 1978 Mar 15; 7(2):183-99. PubMed ID: 209076
    [No Abstract] [Full Text] [Related]

  • 20. Management of breast cancer.
    Cohen IA, Keller JH, Abate MA.
    Clin Pharm; 1982 Mar 15; 1(6):515-29. PubMed ID: 6192963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.